Search Results - "Hedge, Shweta Mahendra"

Abstract 5745: Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC by de Azevedo, Ricardo A., Turner, Broderick, Jayaprakash, Priyamvada, Bhanu, Krithikaa Rajkumar, Srinivasamani, Anupallavi, Morrow, Brittany, Winkler, Michelle, Hedge, Shweta Mahendra, Liu, Arthur, Slay, Ravaen, Curran, Michael A.

“…Despite recently approved immunotherapy combinations, Hepatocellular carcinoma (HCC) remains among the most therapeutically intractable cancers with a 5-year…”
Get full text

Abstract 4213: Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion by de Azevedo, Ricardo Alexandre, Cheng-En, Hsieh, Jayaprakash, Priyamvada, Bhanu, Krithikaa Rajkumar, Srinivasamani, Anupallavi, Morrow, Brittany, Winkler, Michelle, Hedge, Shweta Mahendra, Liu, Arthur, Curran, Michael A.

“…Liver cancer is the fourth most common cause of cancer-related mortality world-wide, and Hepatocellular carcinoma (HCC) is the most common form of liver cancer…”
Get full text